SOFX ALERT
Catching a tumor in a spider’s web: New technology platform exploits the power of protein aggregation to develop novel medicines | ScienceDaily

Catching a tumor in a spider’s web: New technology platform exploits the power of protein aggregation to develop novel medicines | ScienceDaily

After a decade of research, the Belgian Switch Laboratory (VIB/KU Leuven) has revealed a new designer molecule that inhibits a well-validated cancer driver through the mechanism of amyloid formation. This work demonstrates that amyloid structures can be used to rationally develop a novel class of biotechnological molecules that are able to fight a wide array of diseases. After the publication of this research in the journal Science, next steps to translate this groundbreaking technology, branded Pept-inTM into direct benefits for patients are already being explored by VIB.

Source: Catching a tumor in a spider’s web: New technology platform exploits the power of protein aggregation to develop novel medicines — ScienceDaily